Merilog (insulin-aspart-szjj) is the first rapid-acting insulin biosimilar to Novolog (insulin aspart) that is designated to improve glycemic control in adults and adolescents with type 2 diabetes.

From an overall baseline HbA1c of 8.30%, once-weekly IcoSema achieved an estimated reduction in HbA1c of -1.47 percentage points compared with -1.40 percentage points for insulin glargine U100 and ...

Novo Nordisk A/S (NYSE: NVO) announced topline results from the COMBINE 3 phase 3a trial of once-weekly IcoSema, a fixed-ratio combination of basal insulin icodec and semaglutide. Semaglutide is ...

The combination therapy group lost 3.6 kg of body weight at 52 weeks, whereas those receiving insulin glargine and insulin aspart gained 3.2 kg.

Insulin Aspart Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count Novolog Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count ...

In the United States, an estimated 1.3 million adults with diabetes — 16.5 percent of those who have been prescribed insulin to manage their disease — have rationed their use of the medication ...

COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart ...

Insulin Aspart Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count Novolog Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count ...

Insulin Aspart Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count Novolog Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count ...

Insulin Aspart Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count Novolog Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count ...

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage. Skip Navigation ...

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage. Skip Navigation ...